Skip to Main Content

Paper Details

Population-based targeted sequencing of 54 candidate genes identifies <i>PALB2</i> as a susceptibility gene for high-grade serous ovarian cancer.
J Med Genet
25
2021
54, Cancer, EOC, FBXO10, PALB2, POLK, SLX4, cancer, cancer gene panels, candidate genes, coding region, epithelial ovarian cancer, germline, high-grade serous ovarian cancer, ovarian cancer, susceptibility gene, susceptibility genes
Author NameAffiliation
Honglin SongUniversity of Cambridge
Jonathan TyrerUniversity of Cambridge
Maria P IntermaggioUniversity of New South Wales
Maria P IntermaggioUniversity of New South Wales
Georgia Chenevix-TrenchQueensland Institute of Medical Research-QIMR
Georgia Chenevix-TrenchQueensland Institute of Medical Research-QIMR
David D L BowtellPeter MacCallum Cancer Centre
David D L BowtellPeter MacCallum Cancer Centre
Nadia TraficanteThe University of Melbourne
Nadia TraficanteThe University of Melbourne
Aocs Group
Aocs GroupPeter MacCallum Cancer Centre
James D BrentonCancer Research UK Cambridge Institute, University of Cambridge
Teodora GoranovaCancer Research UK Cambridge Institute, University of Cambridge
Anna M PiskorzCancer Research UK Cambridge Institute, University of Cambridge
Jennifer A DohertyHuntsman Institute, University of Utah
Jennifer A DohertyHuntsman Institute, University of Utah
Holly R HarrisFred Hutchinson Cancer Research Center
Holly R HarrisUniversity of Washington
Mary Anne RossingFred Hutchinson Cancer Research Center
Mary Anne RossingUniversity of Washington
Beth Y KarlanDavid Geffen School of Medicine, University of California Los Angeles
Beth Y KarlanWomen's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Jenny LesterDavid Geffen School of Medicine, University of California Los Angeles
Jenny LesterWomen's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Ian G CampbellThe University of Melbourne
Ian G CampbellPeter MacCallum Cancer Centre
Stacey J WinhamMayo Clinic
Chad D HuffUniversity of Texas MD Anderson Cancer Center
Jennifer B PermuthMoffitt Cancer Center
Jennifer B PermuthMoffitt Cancer Center
Douglas A LevineMemorial Sloan Kettering Cancer Center
Douglas A LevineLaura and Isaac Pearlmutter Cancer Center, New York University
Douglas A LevineMemorial Sloan Kettering Cancer Center
Douglas A LevineLaura and Isaac Pearlmutter Cancer Center, New York University
Joellen M SchildkrautUniversity of Virginia
Andrew BerchuckDuke University Hospital
Cezary CybulskiPomeranian Medical University in Szczecin
Jacek GronwaldPomeranian Medical University in Szczecin
Jacek GronwaldPomeranian Medical University in Szczecin
Jennifer AlsopUniversity of Cambridge
Usha MenonMRC Clinical Trials Unit, Institute of Clinical Trials & Methodology, University College London
Usha MenonMRC Clinical Trials Unit, Institute of Clinical Trials & Methodology, University College London
Celeste Leigh PearceUniversity of Michigan School of Public Health ann arbor
Celeste Leigh PearceUniversity of Michigan School of Public Health ann arbor
Anna H WuKeck School of Medicine, University of Southern California
Anna H WuKeck School of Medicine, University of Southern California
Anna DeFazioThe Westmead Institute for Medical Research, The University of Sydney
Anna DeFazioWestmead Hospital
Anna DeFazioThe Westmead Institute for Medical Research, The University of Sydney
  • 1 - 50

Datasets